Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
October 26, 2021

EMA’s CHMP begins rolling review of molnupiravir to treat Covid-19 in adults

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has started a rolling review of molnupiravir (MK-4482 and EIDD-2801), an investigational oral antiviral medicine, to treat adult patients with Covid-19.

Continue
EMA will assess the quality, safety and effectiveness data of molnupiravir. Credit: © 2009-2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
May 13, 2021

CD&R agrees to acquire UDG Healthcare for $3.7bn

UDG provide healthcare advisory, communications, commercial, clinical services. Credit: Arek Socha from Pixabay
May 12, 2021

Lilly, MiNA Therapeutics partner to develop new drug candidates

Lilly will be responsible for activities related to preclinical and clinical development of candidates. Credit: Momoneymoproblemz.

Contracts

October 11, 2021

Brii Biosciences files application for EUA for BRII-196/BRII-198 therapy in US

BRII-196/BRII-198 is a SARS-CoV-2 neutralizing monoclonal antibody combination therapy. Credit: NIAID/ Flickr.

GSK, iTeos Therapeutics to co-develop and co-commercialise cancer drug

BMS signs cancer therapy deal worth $1.5bn with Agenus

Dr. Reddy’s signs license deal for anti-BCMA CAR-T PRG1801 in India

Deals

Deals October 20, 2021

Amgen completes acquisition of biotechnology firm Teneobio

Pharmaceutical Business Review

Pacira BioSciences to buy Flexion Therapeutics

AstraZeneca’s Alexion concludes Caelum acquisition for $500m

Merck signs agreement to buy Acceleron Pharma for $11.5bn

Popular

  1. EC approves Merck’s Keytruda and chemotherapy combination for TNBC patients
  2. Atreca, Gates MRI partner to develop antibody for malaria prevention
  3. BeiGene’s Brukinsa receives approval to treat mantle cell lymphoma in Russia
  4. Moleculin receives approval to start trial of WP1122 for Covid-19 in UK
  5. US FDA approves Oyster Point Pharma’s nasal spray for dry eye disease

PRESS RELEASES

Clinical Maestro 2.4 Brings New Speed and Agility to Clinical Trial Budgeting and Outsourcing
Clinical Maestro 2.4 Brings New Speed and Agility to Clinical Trial Budgeting and Outsourcing
CBDepot Launches the Sale of Synthesized Pharma-Grade CBD
CBDepot Launches the Sale of Synthesized Pharma-Grade CBD
Tosoh Bioscience Completes the Acquisition of Semba Biosciences
Tosoh Bioscience Completes the Acquisition of Semba Biosciences
Gerresheimer at Pharmapack: Type II Glass Injection and Infusion Bottles for Parenteral Applications
Gerresheimer at Pharmapack: Type II Glass Injection and Infusion Bottles for Parenteral Applications
Gx Elite Vials – Injection Vials of the Best Quality, Now Also Ready for Filling In RTF Format
Gx Elite Vials – Injection Vials of the Best Quality, Now Also Ready for Filling In RTF Format

Suppliers

Whitepapers

Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Deuterium-Containing Building Blocks for Drug Design
Deuterium-Containing Building Blocks for Drug Design
CBDepot Progresses in Certification of its Ingredients for Organic and Natural Cosmetics
CBDepot Progresses in Certification of its Ingredients for Organic and Natural Cosmetics